First case of Pasteurella multocida endocarditis of the tricuspid valve: a favorable outcome following medical treatment.
We describe a rare case of tricuspid valve endocarditis caused by Pasteurella multocida in an elderly woman with no previous history of valvular heart disease. Risk factors included contact with animals and old age. The patient was treated successfully with five days of intravenous ampicillin followed by four weeks of oral ciprofloxacin.
Naba
Mazen R
MR
Division of Infectious Diseases, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
Araj
George F
GF
Kanafani
Zeina A
ZA
Kanj
Souha S
SS
D000369:Aged, 80 and over; D000667:Ampicillin / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001769:Blood / Q000382:microbiology; D002939:Ciprofloxacin / Q000627:therapeutic use; D003470:Culture Media; D004452:Echocardiography; D004697:Endocarditis, Bacterial / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology; D005260:Female; D006349:Heart Valve Diseases / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology; D006801:Humans; D010326:Pasteurella Infections / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology; D016979:Pasteurella multocida / Q000187:drug effects / Q000302:isolation & purification; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome; D014261:Tricuspid Valve / Q000382:microbiology*
D000900:Anti-Bacterial Agents; D003470:Culture Media; D002939:Ciprofloxacin; D000667:Ampicillin